turoctocog alfa pegol at a glance
Medicine class
Pegylated recombinant human coagulation factor VIII.
Main use
Prevention and treatment of bleeding in congenital haemophilia A.
How it is given
Injected into a vein after the powder has been mixed with the supplied solvent.
Specialist care
Treatment is started and supervised by a clinician experienced in haemophilia care. Trained patients or carers may administer it at home.
What is turoctocog alfa pegol used for?
It is used for:
Preventing bleeding in people of all ages with haemophilia A caused by congenital factor VIII deficiency.
Treating bleeding episodes in people of all ages with haemophilia A.
Managing haemostasis around surgery in people with haemophilia A.
How does turoctocog alfa pegol work?
Haemophilia A involves absent or reduced factor VIII. Turoctocog alfa pegol replaces this factor. At an injury site, it becomes activated and helps factor IX activate factor X, supporting thrombin and fibrin formation so a stable clot can develop. Its attached polyethylene-glycol component slows clearance before activation, extending factor VIII activity.
turoctocog alfa pegol preparations and strengths
Injection
Route: Parenteral
Strengths: 500 units, 1000 units, 1500 units, 2000 units, 3000 units
How to take turoctocog alfa pegol
The powder is reconstituted only with the supplied sodium chloride solvent, then injected into a vein. Use the clean technique taught by the haemophilia team. Check that the prepared solution is clear and colourless; do not use it if particles or discolouration are present.
Do not mix it with other injections or administer it through the same tubing or container as another medicine.
Use the prepared solution immediately where possible and follow the product leaflet's storage limits if there is a delay.
Do not use the equipment without appropriate training from a doctor or nurse.
Record the product name and batch number after administration.
turoctocog alfa pegol side effects
Common or expected effects
- Reaction at the injection or vein-puncture site, including pain, redness, swelling, rash or bruising
- Itching
- Skin redness
- Rash
Get urgent medical advice
- Severe allergic reaction, including breathing difficulty, wheezing, swelling, widespread hives, low blood pressure or shock
- Factor VIII inhibitors, which may make treatment less effective and cause persistent bleeding
- Reduced factor VIII activity without detectable inhibitors, particularly around a switch to this product
turoctocog alfa pegol in pregnancy
Experience with factor VIII replacement during pregnancy is limited because haemophilia A is uncommon in women. Turoctocog alfa pegol should be used only when clearly indicated, with planning and supervision by the haemophilia and maternity teams.
turoctocog alfa pegol while breastfeeding
There is little direct experience during breastfeeding. Use should be considered only when clearly indicated after discussion with the haemophilia specialist and maternity or primary-care team.
turoctocog alfa pegol interactions
No direct medicine interactions with recombinant factor VIII have been reported, but other treatments can affect bleeding risk or administration.
Aspirin and non-steroidal anti-inflammatory drugs, such as ibuprofen
These may increase bleeding or bruising in people with haemophilia; check with the haemophilia team before use.
Anticoagulants
Blood-thinning treatment may increase bleeding risk and requires specialist coordination.
Other intravenous medicines
Do not mix or administer them in the same tubing or container because compatibility has not been established.
Common questions about turoctocog alfa pegol
Answers are fully visible for fast scanning and source review.
Is turoctocog alfa pegol the same as Esperoct?
Yes. Esperoct is the brand name of a product containing turoctocog alfa pegol.
Is turoctocog alfa pegol made from donated blood?
No. It is produced using recombinant DNA technology rather than extracted from donated human blood.
Does turoctocog alfa pegol cure haemophilia A?
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.